Physician profile
Daniel D Lozano
NPI 1548277148
$18,082.55
in general payments reported to CMS, 2019-2025
7 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.95 · 2020: $2,500 · 2021: $77.55 · 2022: $161 · 2023: $14.33 · 2024: $3,108 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,535 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,413 · Education: $2,276 · Food and Beverage: $1,761 · Honoraria: $1,365 · Consulting Fee: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,535.19 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,413.00 |
| Education | $2,276.00 |
| Food and Beverage | $1,761.43 |
| Honoraria | $1,365.00 |
| Consulting Fee | $910.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $15,229.49 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Organogenesis INC. | $2,582.95 | 2019-2020 | |
| Olympus America INC. | $148.54 | 2022 | |
| Conmed Corporation | $77.55 | 2021 | |
| Solventum Corporation | $16.80 | 2025 | Activ.A.C. |
| Integra Lifesciences Corporation | $14.33 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medline Industries LP | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lozano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.